首页 | 本学科首页   官方微博 | 高级检索  
     

获得性血友病A的治疗进展
引用本文:林欢,黎承平,吴炳芬,冉立. 获得性血友病A的治疗进展[J]. 昆明医科大学学报, 2018, 39(5): 128-131
作者姓名:林欢  黎承平  吴炳芬  冉立
作者单位:昆明医科大学第一附属医院
基金项目:基金: 国家自然科学基金资助项目 (2015FB049); 云南省医疗卫生单位内设研究机构科研基金资助项目 (2017NS047);
摘    要:获得性血友病A是一种由于多种原因导致机体产生凝血因子Ⅷ抗体引起的凝血缺陷性疾病, 该病发病率极低, 且病死率较高, 因该病少见, 故常误诊, 以致延误治疗, 故早期诊断及及时治疗对减少该病的死亡率至关重要.对于该病的治疗原则主要为控制急性出血、根除抑制物、治疗原发病, 故合理及个性化选择治疗方案也很关键.

关 键 词:获得性血友病A   凝血因子Ⅷ   治疗
收稿时间:2017-12-13

Progress in the Treatment of Acquired Hemophilia A
Abstract:Acquired hemophilia A is a deficiency disease caused by blood coagulation factor VIII antibodies due to a variety of causes, The disease incidence rate is extremely low, but the mortality rate is high. This disease is often misdiagnosed, resulting in delays in treatment, so early diagnosis and timely treatment is crucial for reducing the mortality. The principle of treatment for the disease is mainly to control acute bleeding, eradicate inhibitor, and treat the primary disease, therefore, rational and personalized choices of treatment are also critical.
Keywords:
点击此处可从《昆明医科大学学报》浏览原始摘要信息
点击此处可从《昆明医科大学学报》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号